Top 3 Health Care Stocks That May Rocket Higher In September
CVS, Steris and Baxter are oversold healthcare stocks with RSI readings near or below 30, potentially offering undervalued buying opportunities.
Stocks · News reference
CVS Health's Aetna Reduces Administrative Tasks For Cancer Care
CVS unit Aetna expands prior authorization bundles to accelerate cancer care and reduce administrative burdens for healthcare providers.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability
BrightSpring Health Services' Home and Community Pharmacy segment experienced an 8% revenue decline to $540M in Q2, with the Inflation Reduction Act (IRA) accounting for approximately $50M of the impact. Despite a projected $200M revenue headwind in 2026 from IRA pricing changes, the company expects only a $15M EBITDA impact, demonstrating that operational efficiency gains from technology, automation, AI, and Lean initiatives are offsetting regulatory pressures. Peer companies Cardinal Health and CVS Health are similarly navigating IRA-driven revenue pressures while maintaining profitability through service agreements and operational improvements.
CVS Health Unit Aetna Announces Expansion Of Prior Authorization Bundles Across All Cancer Types For Members In Eligible Medicaid States As Of September 1, With Plans To Expand Across All Lines Of Business In 2027
This expansion builds on the success of the initial roll-out, with almost 25% of eligible members receiving a bundled prior authorization, assuring their services have been approved in advance to accelerate their access